LAWRENCE E. LEIBOWITZ - 25 Oct 2022 Form 4 Insider Report for Enfusion, Inc.

Role
Director
Signature
/s/ Blake Nielsen, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
25 Oct 2022
Net transactions value
$0
Form type
4
Filing time
27 Oct 2022, 21:20:40 UTC
Previous filing
01 Sep 2022
Next filing
27 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +7,239 +14% $0.000000 57,601 25 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan (the "Shares").